The PCPT: New Findings, New Insights, and Clinical Implications for the Prevention of Prostate Cancer
- 30 June 2006
- journal article
- Published by Elsevier in European Urology Supplements
- Vol. 5 (9) , 634-639
- https://doi.org/10.1016/j.eursup.2006.05.003
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Endometrial Cancer and TamoxifenClinical Journal of Oncology Nursing, 2005
- Prevention of Prostate Cancer with Finasteride: US/European PerspectiveEuropean Urology, 2003
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Hormones and prostate cancer: Current perspectives and future directionsThe Prostate, 2002
- Prostate Cancer Prevention Trial (PCPT) UpdateEuropean Urology, 1999
- Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trialUrology, 1998
- Prostate Tissue Composition and Response to Finasteride in Men With Symptomatic Benign Prostatic HyperplasiaJournal of Urology, 1997
- The CAG repeat within the androgen receptor gene and its relationship to prostate cancerProceedings of the National Academy of Sciences, 1997
- Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiencyJournal of Clinical Endocrinology & Metabolism, 1992
- 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black malesThe Lancet, 1992